A Hrobjartsson
Overview
Explore the profile of A Hrobjartsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karlsen K, Hrobjartsson A, Korsholm M, Mogensen O, Humaidan P, Ravn P
Arch Gynecol Obstet
. 2017 Oct;
297(1):13-25.
PMID: 29052017
Purpose: The impact of uterine artery embolization (UAE) for the purpose of diminishing the effect of uterine fibroids on fertility is unclear. We have investigated the reported rates of pregnancy...
2.
Hrobjartsson A, Boutron I
Clin Pharmacol Ther
. 2011 Oct;
90(5):732-6.
PMID: 21993424
Blinding, or "masking," is a crucial method for reducing bias in randomized clinical trials. In this paper, we review important methodological aspects of blinding, emphasizing terminology, reporting, bias mechanisms, empirical...
3.
Rud B, Hilden J, Hyldstrup L, Hrobjartsson A
Osteoporos Int
. 2008 Aug;
20(4):599-607.
PMID: 18716823
Summary: We performed a systematic review of studies comparing the Osteoporosis Self-Assessment Tool (OST) and other tests used to select women for bone mineral density (BMD) assessment. In comparative meta-analyses,...
4.
Pildal J, Hrobjartsson A, Jorgensen K, Hilden J, Altman D, Gotzsche P
Int J Epidemiol
. 2007 May;
36(4):847-57.
PMID: 17517809
Background: Randomized trials without reported adequate allocation concealment have been shown to overestimate the benefit of experimental interventions. We investigated the robustness of conclusions drawn from meta-analyses to exclusion of...
5.
Hrobjartsson A, Forfang E, Haahr M, Als-Nielsen B, Brorson S
Int J Epidemiol
. 2007 Apr;
36(3):654-63.
PMID: 17440024
Background: Blinding can reduce bias in randomized clinical trials, but blinding procedures may be unsuccessful. Our aim was to assess how often randomized clinical trials test the success of blinding,...
6.
Rud B, Hilden J, Hyldstrup L, Hrobjartsson A
Osteoporos Int
. 2007 Mar;
18(9):1177-87.
PMID: 17361324
Unlabelled: The Osteoporosis Self-Assessment Tool (OST) is a simple test that may be of clinical value to rule-out low bone mineral density. We performed a systematic review to assess its...
7.
Gotzsche P, Hrobjartsson A
Cochrane Database Syst Rev
. 2005 Jan;
(1):CD000193.
PMID: 15674868
Background: Somatostatin and its derivatives are often used for emergency treatment of bleeding oesophageal varices in patients with cirrhosis of the liver. Objectives: To study whether somatostatin or analogues improve...
8.
Hrobjartsson A, Gotzsche P
Cochrane Database Syst Rev
. 2004 Jul;
(3):CD003974.
PMID: 15266510
Background: Placebo interventions are often claimed to improve patient-reported and observer-reported outcomes, but this belief is not based on evidence from randomised trials that compare placebo with no treatment. Objectives:...
9.
Hrobjartsson A, Gotzsche P
J Intern Med
. 2004 Jul;
256(2):91-100.
PMID: 15257721
Background: It is widely believed that placebo interventions induce powerful effects. We could not confirm this in a systematic review of 114 randomized trials that compared placebo-treated with untreated patients....
10.
Hrobjartsson A, Gotzsche P
Cochrane Database Syst Rev
. 2003 Jan;
(1):CD003974.
PMID: 12535498
Background: Placebo interventions are often believed to improve patient reported and observer reported outcomes, but this belief is not based on evidence from randomised trials that compare placebo with no...